Al Harrington's 12 NBA Surgeries Led Him From Cannabis User to Researcher

Al Harrington endured 12 surgeries during his 16-year NBA career. The physical toll pushed him toward cannabis for pain management, but unlike many athletes who stop at symptom relief, Harrington kept going—straight into the science.

The former forward, who played for seven teams including the Indiana Pacers and Golden State Warriors, has transformed from cannabis consumer to industry advocate and amateur researcher. His journey reflects a broader shift among retired professional athletes who are increasingly vocal about cannabis use while the leagues they played for maintain restrictive policies.

Harrington's interest deepened beyond simple pain relief after years of post-surgical rehabilitation. The repetitive cycle of surgery, recovery protocols, and return-to-play timelines gave him a unique perspective on how cannabis interacted with his body's healing processes.

From the Court to the Lab

The NBA officially prohibits cannabis use, testing players and imposing suspensions for violations. Yet a 2019 survey found that roughly 75% of active NBA players use cannabis, according to estimates from player advocates. The disconnect between policy and practice has made retired players like Harrington essential voices in reform conversations.

Harrington launched Viola, his cannabis brand, in 2011—years before his 2015 retirement. The company now operates in multiple legal markets and has raised millions in venture funding. But his recent focus has shifted toward understanding cannabinoid interactions, terpene profiles, and delivery mechanisms.

The former player has consulted with researchers studying cannabis effects on inflammation and pain pathways. He's also invested in laboratory testing companies that analyze cannabinoid content and contaminants in commercial products.

Industry Impact

Professional athletes entering the cannabis space bring credibility and capital. Harrington joins former players like Kevin Durant, Ricky Williams, and Cliff Robinson (who passed away in 2020) in building cannabis businesses. Their involvement has helped normalize adult use and challenged stigmas around athletic performance and recovery.

The sports-cannabis intersection is growing fast. Athletes now endorse CBD brands, launch their own product lines, and lobby sports leagues for policy changes. The NFL relaxed its cannabis testing in 2020. Major League Baseball removed it from banned substances in 2019. The NBA has discussed policy modifications but hasn't implemented changes.

Harrington's scientific curiosity sets him apart in a crowded field of athlete-backed brands. While many celebrity cannabis companies focus on marketing and distribution, his recent work emphasizes product development informed by research rather than trends.

What's Next

The NBA's next collective bargaining agreement, expected in 2024, could address cannabis policy. Player advocates are pushing for removal from banned substances lists, citing both medical benefits and changing state laws. Roughly 40 states now permit some form of cannabis use.

Harrington continues expanding Viola while consulting on product formulations designed for athletic recovery. His approach—starting with personal experience, then diving into mechanisms of action—mirrors the cannabis industry's broader evolution from anecdotal evidence to clinical research.

For athletes still playing under restrictive league policies, Harrington's trajectory offers a blueprint: survive the career, then help change the rules.

This article is based on original reporting by hightimes.com.